Preclinical evaluation of CDK4/6 inhibitor GLR2007 in glioblastoma models

Lei Yin – Gan & Lee Pharmaceuticals, Beijing, China


Features of treatment of leptomeningeal dissemination for children with rabhomyosarcoma paramenongeal localization with intracranial distribution

Anastasia D. Rodina – Research Center of Oncology, Moscow, Russian Federation

Factors associated with short survival after whole brain radiotherapy for brain metastases in patients with non-small cell lung cancer

Astrid T. Karlsson – Department of Oncology, Oslo University Hospital, Oslo, Norway

Whole brain radiotherapy for melanoma brain metastases – which patients are likely to live ≤3 months after treatment?

Olav E. Yri – Dep of Oncology and European Palliative Care Research Centre (PRC), Oslo University Hospital